Skip to content

Clinical trials

Triple Negative Breast Neoplasms trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Country / region: Portugal Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20172
20182
20193
20201
20212
20221
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting5
Active, not recruiting4
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
AstraZeneca2
Amgen1
Bristol-Myers Squibb1
Celgene1
Centro Hospitalar Universitário de Santo António1
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.1
Fundacao Champalimaud1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms18
Breast Neoplasms8
Carcinoma, Ovarian Epithelial2
Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Uterine Cervical Neoplasms2
Adenocarcinoma of Lung1
Basal Cell Carcinoma1
Breast Diseases1
Carcinoma, Merkel Cell1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.